New drugs will have smaller populations, i.e. markets. This does not bode well, since the cost of developing drugs continue to escalate. No major changes foreseen. The market is mature and will be somewhat limited in expansion by lack of infrastructure. Furthermore, in order to compete with other forms of transport, air travel will have to return to a non-stop model which will require much greater computational resources than have been used to date.
Current aircraft are quite efficient.
Surface Transport Major changes will be in energy sources rather than in production methodology. Developing new methods of storing energy are generating large amounts of investment and research expenditures. It is clear that a combination of regulation and market forces are driving these expenditures. Furthermore, the technology is no longer decades away, but is achievable in the next decade. Infrastructure will be required which will take longer to implement.